Radiolabeled neoglycopeptides

Details Radiolabeled neoglycopeptides Radiolabeled neoglycopeptides

A - Human Necessities

61

K

167/48

A61K 51/08 (2006.01)

Patent

CA 1165234

ABSTRACT OF THE DISCLOSURE Radiopharmaceuticals and method are provided for scintigraphic evaluation of the liver. The radiopharmaceu- ticals comprise a radionuclide (technetium) labeled neoglyco- protein which provides for specific binding of the radio- pharmaceutical to hepatocytes and allows for accurate deter- mination of rates of binding and release of Tc-99m to and from the liver. The observed rates may then be used to determine diseased states, conveniently using an appropriate algorithm for the calculation.

371806

Affiliated with

Also associated with

Rating

Radiolabeled neoglycopeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabeled neoglycopeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled neoglycopeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-720035